SCD and Parkinson disease: This pattern was reversed by SCD inhibitor treatment (compound 5b), providing proof of principle that an FA-related drug known to reverse PD-like phenotypes alters the UPR phenotype of patient-derived neurons (Supplementary Fig. 4C).